TAAR1 and tuberculosis: Considering that abnormal pathogenic immune response cannot be directly corrected by conventional anti-TB therapy, the key to a higher success rate of anti-TB treatment lies in improving cellular immunity.16 Thymosins are important immunomodulatory agents extensively used for adjuvant treatment of chronic infectious diseases.17,18 Thymosins, Tα1 restore and improve immune function significantly.19